The adipokines and inflammatory marker in young type 2 diabetics with metabolic syndrome: A pilot study

Min Jie Wen, Chang Hsun Hsieh, Chung Ze Wu, Fone Ching Hsiao, Te Lin Hsia, Yi Jen Hung, Dee Pei

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Objective: The purpose of the metabolic syndrome (MetS) concept was to early identify subjects having risk for developing cardiovascular diseases and diabetes, which of both are involved in low grade inflammation and obesity. We wish to explore the role of adipokines and inflammatory marker in young type 2 diabetics (YDM) with MetS. Methods: Forty-eight YDM patients were divided to 2 and 3 groups according to the presence of the MetS (MetS+ and MetS-), and the numbers of MetS component (MetS-2 to MetS-4 with 1-2, 3, and 4-5 components) respectively. Plasma adipokines (tumor necrosis factor-α; TNF-α and adiponectin) and C-reactive protein (CRP) were measured and compared among groups. Results: Blood pressure (BP), body mass index (BMI), and plasma triglyceride (TG) levels were higher in the group with MetS+ than that of MetS-. Except for diastolic BP, BMI, waist, and plasma TG levels, which were generally lower in the MetS-2 group, the rest demographic characteristics were not different among these three groups. Finally, the plasma adiponectin, CRP and TNF-αlevels were not different between both groups with or without MetS; and also among these three groups regardless the component numbers they had. Conclusion: YDM with MetS might have non-significant lower adiponectin and higher CRP levels compared to subjects without MetS. It needs prospective study with larger scale to explicit the role of cytokines and inflammatory markers in YDM with MetS.

Original languageEnglish
JournalObesity Research and Clinical Practice
Volume7
Issue number3
DOIs
Publication statusPublished - May 2013

Fingerprint

Adipokines
Adiponectin
C-Reactive Protein
Blood Pressure
Triglycerides
Body Mass Index

Keywords

  • Adiponectin
  • C-reactive protein
  • Metabolic syndrome
  • Tumor necrosis factor-α
  • Young diabetes mellitus

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Nutrition and Dietetics

Cite this

The adipokines and inflammatory marker in young type 2 diabetics with metabolic syndrome : A pilot study. / Wen, Min Jie; Hsieh, Chang Hsun; Wu, Chung Ze; Hsiao, Fone Ching; Hsia, Te Lin; Hung, Yi Jen; Pei, Dee.

In: Obesity Research and Clinical Practice, Vol. 7, No. 3, 05.2013.

Research output: Contribution to journalArticle

Wen, Min Jie ; Hsieh, Chang Hsun ; Wu, Chung Ze ; Hsiao, Fone Ching ; Hsia, Te Lin ; Hung, Yi Jen ; Pei, Dee. / The adipokines and inflammatory marker in young type 2 diabetics with metabolic syndrome : A pilot study. In: Obesity Research and Clinical Practice. 2013 ; Vol. 7, No. 3.
@article{9dde25c5bd7b4c08befc01bec0ae4b67,
title = "The adipokines and inflammatory marker in young type 2 diabetics with metabolic syndrome: A pilot study",
abstract = "Objective: The purpose of the metabolic syndrome (MetS) concept was to early identify subjects having risk for developing cardiovascular diseases and diabetes, which of both are involved in low grade inflammation and obesity. We wish to explore the role of adipokines and inflammatory marker in young type 2 diabetics (YDM) with MetS. Methods: Forty-eight YDM patients were divided to 2 and 3 groups according to the presence of the MetS (MetS+ and MetS-), and the numbers of MetS component (MetS-2 to MetS-4 with 1-2, 3, and 4-5 components) respectively. Plasma adipokines (tumor necrosis factor-α; TNF-α and adiponectin) and C-reactive protein (CRP) were measured and compared among groups. Results: Blood pressure (BP), body mass index (BMI), and plasma triglyceride (TG) levels were higher in the group with MetS+ than that of MetS-. Except for diastolic BP, BMI, waist, and plasma TG levels, which were generally lower in the MetS-2 group, the rest demographic characteristics were not different among these three groups. Finally, the plasma adiponectin, CRP and TNF-αlevels were not different between both groups with or without MetS; and also among these three groups regardless the component numbers they had. Conclusion: YDM with MetS might have non-significant lower adiponectin and higher CRP levels compared to subjects without MetS. It needs prospective study with larger scale to explicit the role of cytokines and inflammatory markers in YDM with MetS.",
keywords = "Adiponectin, C-reactive protein, Metabolic syndrome, Tumor necrosis factor-α, Young diabetes mellitus",
author = "Wen, {Min Jie} and Hsieh, {Chang Hsun} and Wu, {Chung Ze} and Hsiao, {Fone Ching} and Hsia, {Te Lin} and Hung, {Yi Jen} and Dee Pei",
year = "2013",
month = "5",
doi = "10.1016/j.orcp.2011.12.002",
language = "English",
volume = "7",
journal = "Obesity Research and Clinical Practice",
issn = "1871-403X",
publisher = "Elsevier BV",
number = "3",

}

TY - JOUR

T1 - The adipokines and inflammatory marker in young type 2 diabetics with metabolic syndrome

T2 - A pilot study

AU - Wen, Min Jie

AU - Hsieh, Chang Hsun

AU - Wu, Chung Ze

AU - Hsiao, Fone Ching

AU - Hsia, Te Lin

AU - Hung, Yi Jen

AU - Pei, Dee

PY - 2013/5

Y1 - 2013/5

N2 - Objective: The purpose of the metabolic syndrome (MetS) concept was to early identify subjects having risk for developing cardiovascular diseases and diabetes, which of both are involved in low grade inflammation and obesity. We wish to explore the role of adipokines and inflammatory marker in young type 2 diabetics (YDM) with MetS. Methods: Forty-eight YDM patients were divided to 2 and 3 groups according to the presence of the MetS (MetS+ and MetS-), and the numbers of MetS component (MetS-2 to MetS-4 with 1-2, 3, and 4-5 components) respectively. Plasma adipokines (tumor necrosis factor-α; TNF-α and adiponectin) and C-reactive protein (CRP) were measured and compared among groups. Results: Blood pressure (BP), body mass index (BMI), and plasma triglyceride (TG) levels were higher in the group with MetS+ than that of MetS-. Except for diastolic BP, BMI, waist, and plasma TG levels, which were generally lower in the MetS-2 group, the rest demographic characteristics were not different among these three groups. Finally, the plasma adiponectin, CRP and TNF-αlevels were not different between both groups with or without MetS; and also among these three groups regardless the component numbers they had. Conclusion: YDM with MetS might have non-significant lower adiponectin and higher CRP levels compared to subjects without MetS. It needs prospective study with larger scale to explicit the role of cytokines and inflammatory markers in YDM with MetS.

AB - Objective: The purpose of the metabolic syndrome (MetS) concept was to early identify subjects having risk for developing cardiovascular diseases and diabetes, which of both are involved in low grade inflammation and obesity. We wish to explore the role of adipokines and inflammatory marker in young type 2 diabetics (YDM) with MetS. Methods: Forty-eight YDM patients were divided to 2 and 3 groups according to the presence of the MetS (MetS+ and MetS-), and the numbers of MetS component (MetS-2 to MetS-4 with 1-2, 3, and 4-5 components) respectively. Plasma adipokines (tumor necrosis factor-α; TNF-α and adiponectin) and C-reactive protein (CRP) were measured and compared among groups. Results: Blood pressure (BP), body mass index (BMI), and plasma triglyceride (TG) levels were higher in the group with MetS+ than that of MetS-. Except for diastolic BP, BMI, waist, and plasma TG levels, which were generally lower in the MetS-2 group, the rest demographic characteristics were not different among these three groups. Finally, the plasma adiponectin, CRP and TNF-αlevels were not different between both groups with or without MetS; and also among these three groups regardless the component numbers they had. Conclusion: YDM with MetS might have non-significant lower adiponectin and higher CRP levels compared to subjects without MetS. It needs prospective study with larger scale to explicit the role of cytokines and inflammatory markers in YDM with MetS.

KW - Adiponectin

KW - C-reactive protein

KW - Metabolic syndrome

KW - Tumor necrosis factor-α

KW - Young diabetes mellitus

UR - http://www.scopus.com/inward/record.url?scp=84877579442&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84877579442&partnerID=8YFLogxK

U2 - 10.1016/j.orcp.2011.12.002

DO - 10.1016/j.orcp.2011.12.002

M3 - Article

C2 - 23697589

AN - SCOPUS:84877579442

VL - 7

JO - Obesity Research and Clinical Practice

JF - Obesity Research and Clinical Practice

SN - 1871-403X

IS - 3

ER -